Corporate Presentations
Latest Summary Corporate Presentation
View Presentation-
29 Nov 2017
Company presentation: AGM 29 Nov 2017 ACW Managing Director’s presentation
-
16 Oct 2017
Company investor presentation: Oct 2017
-
27 Mar 2017
Company investor presentation: March 2017
-
30 Nov 2016
Company presentation: AGM 30 Nov 2016 ACW CEO presentation
-
10 Mar 2016
Company investor presentation: Developing Xanamem for Alzheimer’s disease – Cortisol Hypothesis: March 2016
-
12 Nov 2015
Company presenation: AGM 12 Nov 2015 ACW CEO presentation
-
14 Apr 2015
Teleconference call transcript: Xanamem™ Clinical Advisory Board Conference Call
-
13 Apr 2015
Company investor presentation: Developing Xanamem™ for Alzheimer’s Dementia: April 2015
-
09 Mar 2015
Company investor presentation: Developing Xanamem™ for Alzheimer’s Dementia: March 2015
2024 Annual General Meeting
Actinogen’s next Annual General Meeting
Date: 14 November 2024
Read more